Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER

NACompletedINTERVENTIONAL

Enrollment

370

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions

Pulmonary Disease, Chronic Obstructive Patients Admitted in Emergency Department for Acute Exacerbation

Interventions

OTHER

AECOPD Mr proADM

Trial Locations (2)

Hôpital Lariboisière, Paris

Pitié Salpétrière Hospital, Paris

All Listed Sponsors

collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

lead

ThermoFisher Scientific Brahms Biomarkers France

INDUSTRY

NCT01857947 - Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER | Biotech Hunter | Biotech Hunter